Sorbitol

Sorbitol

SCHEMBL3227835

O=S(=O)(O)O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CO

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sorbitol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
TDP1 Q9NUW8 1/20 0.65
PDE4A P27815 1/20 0.52
USP2 O75604 1/20 0.48
SLCO1B1 Q9Y6L6 1/20 0.48
KDM4E B2RXH2 2/20 0.46
CA5A P35218 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
TP53 P04637 1/20 0.36
MGAM O43451 2/20 0.36
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32
TOP1 P11387 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mannitol SCHEMBL3887158 1.00 LMNA (0.69) LMNAL3MBTL1TDP1PDE4AUSP2
Mannitol SCHEMBL20572201 1.00 LMNA (0.69) LMNAL3MBTL1TDP1PDE4AUSP2
Mannitol SCHEMBL29080611 0.97 LMNA (0.65) LMNAL3MBTL1TDP1PDE4AUSP2
Sorbitol SCHEMBL628565 0.97 LMNA (0.65) LMNAL3MBTL1TDP1PDE4AUSP2
Sorbitol SCHEMBL15993963 0.97 LMNA (0.65) LMNAL3MBTL1TDP1PDE4AUSP2
Mannitol SCHEMBL29080612 0.97 LMNA (0.65) LMNAL3MBTL1TDP1PDE4AUSP2
Adonitol SCHEMBL20481269 0.94 LMNA (0.59) LMNAL3MBTL1TDP1PDE4AUSP2
Mannitol SCHEMBL31109182 0.92 PDE4A (0.58) LMNAL3MBTL1TDP1PDE4AUSP2
Mannitol SCHEMBL7249316 0.88 LMNA (0.61) LMNAL3MBTL1TDP1PDE4AUSP2
Sulfuric Acid SCHEMBL23754263 0.87 LMNA (0.52) LMNAL3MBTL1TDP1PDE4AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-62215510-A None JP disclosed
JP-8081351-A None JP disclosed
US-20240189398-A1 LIQUID COMPOSITION COMPRISING FACTOR VIII OR FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX GRIFOLS WORLDWIDE OPERATIONS LIMITED (IE) 2024-06-13 US disclosed
EP-4322918-A1 LIQUID COMPOSITION COMPRISING FACTOR VIII OR FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX Grifols Worldwide Operations Limited (IE) 2024-02-21 EP disclosed
CN-117136046-A Liquid composition comprising factor VIII or factor VIII/von willebrand factor complex 基立福环球运营有限公司 2023-11-28 CN disclosed
WO-2023160616-A1 A HYDROGEL COMPOSITION FOR PREPARING CUSTOMIZED MASK PACK BASF SE (DE) 2023-08-31 WO disclosed
US-20100062029-A1 Product for the Targeted Release of Active Substances LTS LOHMANN THERAPIE-SYSTEME AG (DE) 2010-03-11 US disclosed
US-20080145388-A1 cosmetic cleaning product for controlling release; two layers define a compartment between them, which contains the active substance and optionally a gas-releasing component; one is impermeable, and one is permeable to the active substance; single use for body care; glove shape LTS LOHMANN THERAPIE-SYSTEME AG (DE) 2008-06-19 US disclosed
US-20060052263-A1 Soap preparation with air bubbles SCS SKIN CARE SYSTEMS GMBH 2006-03-09 US disclosed
CN-1192780-C Therapeutical agent TAKARA SHUZO CO (JP) 2005-03-16 CN disclosed
CN-1355703-A Therapeutical agent TAKARA SHUZO CO (JP) 2002-06-26 CN disclosed
EP-1175907-A1 REMEDIES Takara Shuzo Co, Ltd. (JP) 2002-01-30 EP disclosed
WO-1999007339-A1 COMPOSITIONS FOR VISUALLY IMPROVING SKIN THE PROCTER & GAMBLE COMPANY (US) 1999-02-18 WO disclosed
JP-H0881351-A CUTICLE KERATINIZATION PROMOTING AGENT KANEBO LTD 1996-03-26 JP disclosed
JP-S62215510-A EMULSIFIED COMPOSITION SHISEIDO CO LTD 1987-09-22 JP disclosed